PRAX Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own PRAX shares is 195, representing 107.48% of the company's common stock.

CORMORANT ASSET MANAGEMENT, LP, in the last quarter, reduced its stake in PRAX by -100% restricting it's holding to 0 shares of worth nearly -. SPHERA FUNDS MANAGEMENT LTD. also lessened -93.22% of the PRAX shares from its portfolio, reducing its holding to 328.99 thousand shares of worth $7.33M. BAKER BROS. ADVISORS LP also shunned PRAX shares holding by -93% last quarter which brought its holding to 131.53 thousand shares worth $2.93M.

As per its latest 13F filing, PFM HEALTH SCIENCES, LP increased its stake in PRAX by 0.32% in the last quarter. The institutional holder raised its holding to 8.92 million shares having worth more than $15.25M. ADAGE CAPITAL PARTNERS GP, L.L.C. also added 10.71% more shares of PRAX to its portfolio, raising its holding to 8.78 million shares of worth $15.01M. VANGUARD GROUP INC also increased its PRAX shares holding by 135.31% which brought its holding to 5.56 million shares worth $9.51M.

The insider with the most stakes in PRAX is Vitorovic Stefan , director at the company. Additionally, PRAX stock is highly held by director MITCHELL DEAN J and Chief Financial Officer Kelly Timothy Edwin among others.

Company executives, directors, and other insiders own 0.24% percent of Praxis Precision Medicines, Inc.'s stock. Within the last six months, there have been 2 transaction(s) in which PRAX insiders have sold stock, totaling 13.43K shares. Insiders that have sold shares include NEMIROFF ALEX, MASTROCOLA LAUREN, and BSOF PARALLEL MASTER FUND L.P..

There have been 0 transaction(s) during the past 6-months in which Praxis Precision Medicines, Inc. insiders have bought stock, totalling 0 shares

Around 15.91K Praxis Precision Medicines, Inc. shares are held by insiders, which represents about 0.24% of PRAX stock.

PRAX director, Vitorovic Stefan holds the largest portfolio of the company's shares. PRAX shares owned by Vitorovic total nearly 2.94 million.

CORMORANT ASSET MANAGEMENT, LP is the largest institutional owner in PRAX which holds 0 shares worth - or 0% of the total PRAX shares outstanding followed by SPHERA FUNDS MANAGEMENT LTD. with ownership of 328.99 thousand shares representing 0.24% of the PRAX ownership. BAKER BROS. ADVISORS LP is the third largest stakeholder with 131.53 thousand shares or 0.1% of the ownership worth more than $2.93M.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the PRAX is concerned, it is a stock which is optionable.

Number of PRAX shares short is 2.62M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 18.64M shares of PRAX are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, PRAX has 14.71M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for PRAX is 7.66.